Remove 2026 Remove FDA Remove Health Outcomes Remove Patient Satisfaction
article thumbnail

Intelerad Acquires PenRad Technologies, Inc., Expanding Breast Imaging and Lung Screening Capabilities

Healthcare IT Today

The acquisition will expand Intelerad’s product offerings for mammography and lung analytics, optimizing workflows for radiologists and boosting health outcomes for patients. billion by 2026. PenRad is at the front lines of care as demand surges. The acquisition of PenRad is an exciting milestone for Intelerad.